Callan Capital’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $601K | Sell |
11,700
-300
| -3% | -$15.4K | 0.04% | 181 |
|
|
2024
Q4 | $664K | Sell |
12,000
-3,400
| -22% | -$188K | 0.05% | 142 |
|
|
2024
Q3 | $507K | Buy |
15,400
+600
| +4% | +$19.7K | 0.04% | 173 |
|
|
2024
Q2 | $402K | Buy |
14,800
+800
| +6% | +$21.7K | 0.03% | 189 |
|
|
2024
Q1 | $509K | Sell |
14,000
-2,950
| -17% | -$107K | 0.04% | 140 |
|
|
2023
Q4 | $343K | Buy |
16,950
+1,750
| +12% | +$35.4K | 0.03% | 163 |
|
|
2023
Q3 | $270K | Buy |
15,200
+450
| +3% | +$8K | 0.03% | 167 |
|
|
2023
Q2 | $267K | Buy |
14,750
+450
| +3% | +$8.13K | 0.03% | 151 |
|
|
2023
Q1 | $180K | Buy |
14,300
+2,700
| +23% | +$33.9K | 0.02% | 173 |
|
|
2022
Q4 | $170K | Buy |
+11,600
| New | +$170K | 0.02% | 178 |
|